Accueil・Liste d'Actions・CorMedix Inc

CorMedix Inc

Ouvert

SecteurSoins de santé

7.51

Acheter Vendre

Résumé

Variation du prix de l'action

24h

Actuel

Min

7.36

Max

7.55

Chiffres clés
By Trading Economics
Revenu	25M 39M
Ventes	-1.2M 127M
P/E Moyenne du Secteur	3.636 64.641
BPA	0.35
Marge bénéficiaire	30.293
Employés	191
EBITDA	-289K 66M

Recommandations
By TipRanks
Recommandations	Achat Fort
Prévisions sur 12 Mois	+85.92% upside

Dividendes
By Acuity
Prochains Résultats	13 août 2026

Statistiques du Marché
By TradingEconomics
Capitalisation Boursière	-4.6M 596M
Ouverture précédente	7.51
Clôture précédente	7.51

Sentiment de l'Actualité

By Acuity

100%

320 / 340 Classement par Healthcare

CorMedix Inc Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

31 juil. 2026, 22:01 UTC

CorMedix Inc shares are lower in after-market hours, continuing a trend of weak trading. The stock is near its one-month low and below its 20-day average.

30 juil. 2026, 20:08 UTC

CorMedix Inc shares are trading higher, reflecting a notable early spike despite broader market volatility and mixed economic signals.

29 juil. 2026, 19:27 UTC

CorMedix Inc shares are lower today, continuing a four-session decline. The asset reached a session high before dropping to midday lows.

28 juil. 2026, 18:36 UTC

CorMedix Inc. shares are lower today amid broader market declines, influenced by significant drops in Asian indices, including the Nikkei 225 Index.

27 juil. 2026, 23:01 UTC

CorMedix Inc shares are higher in after-market trading, rising notably despite being below its 20-day moving average and near the lower end of its monthly range.

24 juil. 2026, 17:56 UTC

CorMedix Inc's shares are declining, with no specific news identified. The stock remains below its 20-day moving average and near the lower end of its one-month range.

23 juil. 2026, 21:51 UTC

CorMedix Inc shares declined in after-market trading, moving lower despite broader market resilience and turmoil in the bond market. No specific news was identified.

22 juil. 2026, 23:11 UTC

CorMedix Inc. shares are higher in after-market hours, following notable activity. The stock remains below its 20-day moving average.

21 juil. 2026, 19:31 UTC

CorMedix Inc. shares are higher today, reflecting strong buying activity. The stock has gained momentum since Monday's close, despite remaining below its 20-day moving average.

20 juil. 2026, 22:01 UTC

CorMedix Inc shares are higher in after-market trading, reflecting a notable rise since Monday's close, despite being below its 20-day moving average.

Comparaison

Variation de prix

CorMedix Inc prévision

Objectif de Prix

By TipRanks

85.92% hausse

Prévisions sur 12 Mois

Moyen 14 USD 85.92%

Haut 15 USD

Bas 13 USD

Basé sur 5 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Achat Fort

5 ratings

Achat

Maintien

Vente

Basé sur 5 qui ont noté l'action Microsoft Corp. au cours des 3 derniers mois.

Sentiment

By Acuity

320 / 340Classement par Soins de santé

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

À Propos CorMedix Inc

CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases in the United States. Its lead product candidate is DefenCath, an antimicrobial catheter lock solution to reduce the incidence of catheter-related bloodstream infections in adult patients with kidney failure. The company was formerly known as Picton Holding Company, Inc. and changed its name to CorMedix, Inc. in January 2007. CorMedix Inc. was incorporated in 2006 and is based in Berkeley Heights, New Jersey.